AVITA Medical, Inc. (RCEL)
NASDAQ: RCEL · Real-Time Price · USD
3.790
-0.050 (-1.30%)
Nov 21, 2025, 4:00 PM EST - Market closed
AVITA Medical Market Cap
AVITA Medical has a market cap or net worth of $115.57 million as of November 21, 2025. Its market cap has decreased by -61.00% in one year.
Market Cap
115.57M
Enterprise Value
137.03M
1-Year Change
-61.00%
Ranking
Category
Stock Price
$3.79
Market Cap Chart
Since October 2, 2019, AVITA Medical's market cap has decreased from $666.70M to $115.57M, a decrease of -82.67%. That is a compound annual growth rate of -24.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2025 | 117.10M | -65.11% |
| Dec 31, 2024 | 335.60M | -4.28% |
| Dec 29, 2023 | 350.60M | 112.23% |
| Dec 30, 2022 | 165.20M | -44.68% |
| Dec 31, 2021 | 298.60M | -25.68% |
| Dec 31, 2020 | 401.80M | -52.81% |
| Dec 31, 2019 | 851.40M | 27.70% |
| Oct 2, 2019 | 666.70M | - |
View and export this data all the way back to 2019. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 939.79B |
| Johnson & Johnson | 487.91B |
| AbbVie | 411.64B |
| UnitedHealth Group | 279.99B |
| AstraZeneca | 275.69B |
| Novartis AG | 243.58B |
| Merck & Co. | 235.92B |
| Abbott Laboratories | 219.36B |